Chemring Group (CHG) Share Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemring Group in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CHG shares.
View CHG analyst ratings or view top-rated stocks.

2 Wall Street research analysts have issued 1-year price objectives for Chemring Group's stock. Their CHG share price forecasts range from GBX 380 to GBX 380. On average, they predict the company's stock price to reach GBX 380 in the next year. This suggests a possible upside of 34.8% from the stock's current price.
View analysts price targets for CHG or view top-rated stocks among Wall Street analysts.

Chemring Group's stock was trading at GBX 297.50 at the start of the year. Since then, CHG stock has decreased by 5.2% and is now trading at GBX 282.
View the best growth stocks for 2023 here.

Chemring Group PLC (LON:CHG) posted its quarterly earnings data on Thursday, January, 17th. The company reported $6.90 EPS for the quarter, missing the consensus estimate of $8.70 by $1.80. Chemring Group had a trailing twelve-month return on equity of 10.05% and a net margin of 9.11%.

Chemring Group announced a dividend on Tuesday, June 6th. Investors of record on Thursday, August 17th will be given a dividend of GBX 2.30 per share on Friday, September 8th. This represents a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, August 17th. The official announcement can be seen at this link.
Read our dividend analysis for CHG.

Chemring Group (LON:CHG) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 2.00%. The dividend payout ratio is 4,285.71%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CHG.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemring Group investors own include Avon Protection (AVON), KAZ Minerals (KAZ), Barclays (BARC), Celanese (CE), Avesoro Resources (ASO), Hawaiian (HA), KCOM Group (KCOM), Unilever (ULVR) and Alpine Immune Sciences (ALPN).

Chemring Group trades on the London Stock Exchange (LON) under the ticker symbol "CHG."

Shares of CHG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of CHG stock can currently be purchased for approximately GBX 282.

Chemring Group (LON:CHG) has a market capitalization of £798.23 million and generates £434.50 million in revenue each year. The company earns £39.60 million in net income (profit) each year or GBX 0.14 on an earnings per share basis.

The company employs 2,500 workers across the globe.

Chemring Group's mailing address is Roke Manor, Old Salisbury Lane, ROMSEY, SO51 0ZN, United Kingdom. The official website for the company is www.chemring.co.uk. The company can be reached via phone at +44-1794-833901.